SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.865
-0.065 (-1.65%)
Mar 5, 2026, 9:55 AM EST - Market open
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 1.32M | 2.24M | 23.90M | 60.88M | 55.24M | |
| -40.94% | -90.63% | -60.73% | 10.21% | 1504.91% | |
| 1.32M | 2.24M | 23.90M | 60.88M | 55.24M | |
| -40.94% | -90.63% | -60.73% | 10.21% | 1504.91% | |
Source: S&P Global Market Intelligence.
